Today: 28 June 2026
Uber stock slides as robotaxi partner Waabi raises $1B and Uber rolls out AV Labs
28 January 2026
2 mins read

Uber stock slides as robotaxi partner Waabi raises $1B and Uber rolls out AV Labs

New York, Jan 28, 2026, 14:30 EST — Regular session

  • Uber shares slipped 1.4% in afternoon trading, following a modest retreat in U.S. equities
  • Waabi announced a $750 million funding round and a robotaxi agreement to deploy over 25,000 vehicles on Uber gradually
  • Uber also introduced “AV Labs,” a new unit focused on collecting real-world driving data to support its self-driving partners

Shares of Uber Technologies (UBER) slid 1.4% Wednesday, closing at $80.09. Investors digested the company’s renewed focus on autonomous vehicles alongside a funding round at self-driving startup Waabi.

Timing is crucial. Uber’s quarterly report drops in a few days, and investors are bracing for signs of margin discipline after the stock’s recent rally and a surge of pricey bets in tech and mobility sectors.

This move throws Uber’s “platform” strategy back into focus — not making robotaxis on its own, but aiming to be the hub for self-driving fleets as they expand. The payoff? More rides, cheaper prices. But the gamble is that autonomous tech could lag or get undercut by competitors and partners.

Waabi announced it has wrapped up an oversubscribed $750 million Series C funding round and locked in extra milestone-based capital from Uber. The deal is linked to a partnership where Waabi’s robotaxi software will be used exclusively on Uber’s platform. Uber CEO Dara Khosrowshahi described Waabi’s robotaxi effort as “an important milestone” in a statement highlighted in Waabi’s announcement. Waabi

TechCrunch reported that Uber’s investment linked to the robotaxi rollout was about $250 million, with no set deadline for launching 25,000 or more vehicles on the platform. The report noted Waabi’s entry expands Uber’s lineup of autonomous vehicle partners.

Uber is tackling a different challenge: data. The company just launched “AV Labs,” a team dedicated to creating a “data flywheel” — a cycle where real-world trips generate edge-case driving data to enhance self-driving tech. Uber CTO Praveen Neppalli Naga told TechCrunch, “Our goal, primarily, is to democratize this data,” and stressed that Uber won’t be charging for it “at least not yet.” Uber

The broader market was uneven following the Federal Reserve’s decision to keep interest rates steady, as investors sifted through the statement looking for clues on potential rate cuts.

Shares of other gig-economy companies dipped as well: Lyft dropped roughly 1.5%, while DoorDash edged down about 0.5%.

The robotaxi narrative remains anything but straightforward. Neither Uber nor Waabi has announced a firm launch date, and autonomy projects have a habit of missing deadlines as safety concerns, regulatory hurdles, and costs come into play. Even with a vast network, the financials hinge on fleet ownership, liability responsibilities, and how the revenue split shakes out.

Regulation remains in focus. On Tuesday, a Dutch court reversed a 2021 ruling that labeled all Uber drivers as employees, deciding that the drivers involved can be considered independent entrepreneurs. Uber hailed the judgment as “a clear victory” for drivers aiming to maintain independent status. Reuters

Uber is set to release its fourth-quarter and full-year 2025 earnings on Feb. 4, before U.S. markets open. Investors will be watching closely for updates on bookings, profit margins, and any expenses related to its autonomy partnerships.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Parabilis Medicines IPO Surges 58%, Outperforming SpaceX Debut with Regeneron Backing
    June 27, 2026, 8:35 PM EDT. Parabilis Medicines surged 58% on its June 10 IPO, significantly outpacing SpaceX's 19% debut rise. The biotech specializes in Helicons, innovative helical peptides targeting 'undruggable' protein surfaces within cells, aiming to block disease-driving interactions. Its lead drug candidate, zolucatetide, targets a notoriously difficult protein pathway and enters Phase 3 trials in 2027. Early clinical data show promising tumor response rates with minimal toxicity in desmoid tumor patients, though follow-up and trial design limit conclusions. Regeneron's investment signals confidence amid the high risks typical of oncology drug development. Parabilis' unique technology and progressing pipeline position it as a notable contender despite longstanding challenges in drugging flat protein targets, reflecting cautious optimism for long-term investors.

Latest articles

Hecla Mining (NYSE:HL) sees stock rebound, volume jumps as silver prices in focus

Hecla Mining (NYSE:HL) sees stock rebound, volume jumps as silver prices in focus

28 June 2026
Hecla Mining surged 5.3 times its average trading volume Friday as index rebalancing drove 112.44 million shares traded, but the stock’s 2.6% weekly drop still beat silver and peer ETFs, signaling company-specific strength; investors now watch if Hecla can hold above $15.54 without rebalancing flows as macro risks loom.
Oracle stock price today: ORCL edges higher as TikTok outage and new cloud wins grab focus
Previous Story

Oracle stock price today: ORCL edges higher as TikTok outage and new cloud wins grab focus

Intuit stock price dips as AI fears circle TurboTax, but RBC sticks with $850 target
Next Story

Intuit stock price dips as AI fears circle TurboTax, but RBC sticks with $850 target

Go toTop